Hepatitis B virus (HBV) infection remains a major public health problem worldwide with more than 240 million individuals chronically infected. Current treatments can control HBV replication to a large extent, but cannot eliminate HBV infection. Cytokines have been shown to control HBV replication and contribute to HBV cure in different models. Cytokines play an important role in limiting acute HBV infection in patients and mediate a non-cytolytic clearance of the virus. In this review, we summarize the effects of cytokines and cytokine-induced cellular signaling pathways on different steps of the HBV life cycle, and discuss possible strategies that may contribute to the eradication of HBV through innate immune activation
Hepatitis B virus (HBV) infection is a leading cause of liver damage and hepatic inflammation. Upon ...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
The global burden of Hepatitis B virus infection remains high despite the availability of a highly e...
Hepatitis B virus (HBV) infection remains a major public health problem worldwide with more than 240...
Hepatitis B virus (HBV) infection is still one of the most dangerous viral illnesses. HBV infects ar...
Abstract Hepatitis B virus (HBV) infection has a low rate of chronicity compared to HC...
Chronic hepatitis B virus (HBV) infection is a major cause of liver disease and cancer worldwide. Wh...
Chronic hepatitis B virus (HBV) infection is a major cause of liver disease and cancer worldwide. Wh...
HBV is a hepatotropic and non-cytopathic virus that causes more than one million deaths annually fro...
Human hepatitis B virus (HBV) infects the liver of humans or humanoid primates. In humans, HBV infec...
Chronic hepatitis B (CHB) is a widespread infectious disease with unfavorable outcomes and life-thre...
Immune defense against infection with the hepatitis B virus (HBV) is complex and involves both host ...
Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has acc...
Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has acc...
International audienceBackground & Aims: The outcome of hepatitis B virus (HBV) infection may be inf...
Hepatitis B virus (HBV) infection is a leading cause of liver damage and hepatic inflammation. Upon ...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
The global burden of Hepatitis B virus infection remains high despite the availability of a highly e...
Hepatitis B virus (HBV) infection remains a major public health problem worldwide with more than 240...
Hepatitis B virus (HBV) infection is still one of the most dangerous viral illnesses. HBV infects ar...
Abstract Hepatitis B virus (HBV) infection has a low rate of chronicity compared to HC...
Chronic hepatitis B virus (HBV) infection is a major cause of liver disease and cancer worldwide. Wh...
Chronic hepatitis B virus (HBV) infection is a major cause of liver disease and cancer worldwide. Wh...
HBV is a hepatotropic and non-cytopathic virus that causes more than one million deaths annually fro...
Human hepatitis B virus (HBV) infects the liver of humans or humanoid primates. In humans, HBV infec...
Chronic hepatitis B (CHB) is a widespread infectious disease with unfavorable outcomes and life-thre...
Immune defense against infection with the hepatitis B virus (HBV) is complex and involves both host ...
Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has acc...
Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has acc...
International audienceBackground & Aims: The outcome of hepatitis B virus (HBV) infection may be inf...
Hepatitis B virus (HBV) infection is a leading cause of liver damage and hepatic inflammation. Upon ...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
The global burden of Hepatitis B virus infection remains high despite the availability of a highly e...